Bladex, Inc. (BLX) stock analysis
Close on Nov 13, 2026Market cap $1.88BP/E 8.3Yield –
StockData Score
Prices as of Nov 13, 2026How the score works
Weak3 of 30 checks passed
Bladex passes 3 of the 30 checks behind our score; 26 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 3/6
- Past performance
- 0/6
- Financial health
- 0/6
- Dividend
- 0/6
What stands out
Revenue growing 10%+ a year
Revenue grew 26.8% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 34.0% a year over the last three fiscal years.
Growing faster than the industry
Revenue grew 11.8% over the last twelve months; the Commercial Banks median is 11.3%.
What to watch
No dividend
Bladex has not paid a dividend in the last twelve months.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
P/S against the industry
Not enough revenue data to compare.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth3/6
Revenue growing 10%+ a year
Revenue grew 26.8% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 34.0% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 11.8% over the last twelve months; the Commercial Banks median is 11.3%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance0/6
Return on equity
Needs positive equity and five years of results.
Return on assets
Needs net income and total assets.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health0/6
Well capitalized
Needs equity and total assets.
Loans funded by deposits
Needs loans and deposits.
Adequate loan-loss reserve
The allowance for credit losses is not reported.
Efficient operations
Needs non-interest expense and revenue.
Deposits growing
Needs deposits a year ago.
Borrowings
Needs debt and equity figures.
Dividend0/6
No dividend
Bladex has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Bladex. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $9.54M
- Value traded per 1% price move
- $8.62M
Downside
Low risk
- Typical loss in a bad month
- 9.1%
- Volatility (annualized)
- 24%
- Sharpe ratio, 1 year
- 0.33
- Beta to the S&P 500 (5Y)
- 0.59
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Operating margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +11.8% | +26.8% | +27.9% | +95.1% | |
| Operating income | +11.8% | +26.8% | +27.9% | +6.9% | |
| EPS, diluted | +9.1% | +34.0% | +30.7% | +8.7% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Interest coverage | 1.9× | 1.1× | 0.7× | |
| Capex to revenue | 2.4% | 1.0% | – | |
| Diluted shares | 0M | 0M | 37M |
Cash use needs five years of cash flow figures
Bladex does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$780.24M
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income$780.24M vs –
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise37M → 37M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.03 → 0.03
See a number that looks wrong?